Mariner Investment Group’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,277
Closed -$351K 26
2022
Q4
$351K Sell
25,277
-58,389
-70% -$824K 1.03% 27
2022
Q3
$1.14M Sell
83,666
-3,904
-4% -$58K 1.27% 12
2022
Q2
$1.28M Sell
87,570
-1,113
-1% -$17.2K 1.35% 8
2022
Q1
$1.47M Buy
88,683
+20,857
+31% +$366K 1.85% 7
2021
Q4
$1.32M Buy
+67,826
New +$1.32M 0.56% 13

Other funds holding BCAT

Mariner Investment Group's BCAT Position: Q1 2023 in Review

Mariner Investment Group sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2023, closing a stake of 25,277 shares — an estimated $351K sold.

Mariner Investment Group first reported a position in BCAT in Q4 2021 and held it in 5 quarters. The position peaked at $1.47M in Q1 2022. 72 funds tracked by Wall St. Rank hold BCAT as of Q1 2023.

  • Mariner Investment Group reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2023 after selling out during the quarter.
  • Mariner Investment Group sold 25,277 BlackRock Capital Allocation Term Trust shares in Q1 2023, an estimated $351K.
  • Mariner Investment Group first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and held it in 5 quarters.
  • Mariner Investment Group's BlackRock Capital Allocation Term Trust position peaked at $1.47M in Q1 2022.
  • 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2023.

Based on Mariner Investment Group's 13F filing for Q1 2023, filed 12 May 2023.